UNLABELLED: Hereditary tyrosinemia type I (HT1) results in hepatic failure, cirrhosis, and hepatocellular carcinoma (HCC) early in childhood and is caused by a deficiency in the enzyme fumarylacetoacetate hydrolase (FAH). In a novel approach we used the chimeric adeno-associated virus DJ serotype (AAV-DJ) and homologous recombination to target and disrupt the porcine Fah gene. AAV-DJ is an artificial chimeric AAV vector containing hybrid capsid sequences from three naturally occurring serotypes (AAV2, 8, and 9). The AAV-DJ vector was used to deliver the knockout construct to fetal pig fibroblasts with an average knockout targeting frequency of 5.4%. Targeted Fah-null heterozygote fibroblasts were used as nuclear donors for somatic cell nuclear transfer (SCNT) to porcine oocytes and multiple viable Fah-null heterozygote pigs were generated. Fah-null heterozygotes were phenotypically normal, but had decreased Fah transcriptional and enzymatic activity compared to wildtype animals. CONCLUSION: This study is the first to use a recombinant chimeric AAV vector to knockout a gene in porcine fibroblasts for the purpose of SCNT. In using the AAV-DJ vector we observed targeting frequencies that were higher than previously reported with other naturally occurring serotypes. We expect that the subsequent generation of FAH-null homozygote pigs will serve as a significant advancement for translational research in the areas of metabolic liver disease, cirrhosis, and HCC.
UNLABELLED: Hereditary tyrosinemia type I (HT1) results in hepatic failure, cirrhosis, and hepatocellular carcinoma (HCC) early in childhood and is caused by a deficiency in the enzyme fumarylacetoacetate hydrolase (FAH). In a novel approach we used the chimeric adeno-associated virus DJ serotype (AAV-DJ) and homologous recombination to target and disrupt the porcine Fah gene. AAV-DJ is an artificial chimeric AAV vector containing hybrid capsid sequences from three naturally occurring serotypes (AAV2, 8, and 9). The AAV-DJ vector was used to deliver the knockout construct to fetal pig fibroblasts with an average knockout targeting frequency of 5.4%. Targeted Fah-null heterozygote fibroblasts were used as nuclear donors for somatic cell nuclear transfer (SCNT) to porcine oocytes and multiple viable Fah-null heterozygote pigs were generated. Fah-null heterozygotes were phenotypically normal, but had decreased Fah transcriptional and enzymatic activity compared to wildtype animals. CONCLUSION: This study is the first to use a recombinant chimeric AAV vector to knockout a gene in porcine fibroblasts for the purpose of SCNT. In using the AAV-DJ vector we observed targeting frequencies that were higher than previously reported with other naturally occurring serotypes. We expect that the subsequent generation of FAH-null homozygote pigs will serve as a significant advancement for translational research in the areas of metabolic liver disease, cirrhosis, and HCC.
Authors: Shawn C Walker; Taeyoung Shin; Gretchen M Zaunbrecher; Juan E Romano; Greg A Johnson; Fuller W Bazer; Jorge A Piedrahita Journal: Cloning Stem Cells Date: 2002
Authors: Yue Yu; James E Fisher; Joseph B Lillegard; Brian Rodysill; Bruce Amiot; Scott L Nyberg Journal: Liver Transpl Date: 2012-01 Impact factor: 5.799
Authors: Clara T Nicolas; Raymond D Hickey; Kari L Allen; Zeji Du; Rebekah M Guthman; Robert A Kaiser; Bruce Amiot; Aditya Bansal; Mukesh K Pandey; Lukkana Suksanpaisan; Timothy R DeGrado; Scott L Nyberg; Joseph B Lillegard Journal: Surgery Date: 2018-06-06 Impact factor: 3.982
Authors: Faysal Elgilani; Shennen A Mao; Jaime M Glorioso; Meng Yin; Ianko D Iankov; Anisha Singh; Bruce Amiot; Piero Rinaldo; Ronald J Marler; Richard L Ehman; Markus Grompe; Joseph B Lillegard; Raymond D Hickey; Scott L Nyberg Journal: Am J Pathol Date: 2016-11-14 Impact factor: 4.307
Authors: Raymond D Hickey; Shennen A Mao; Bruce Amiot; Lukkana Suksanpaisan; Amber Miller; Rebecca Nace; Jaime Glorioso; Michael K O'Connor; Kah Whye Peng; Yasuhiro Ikeda; Stephen J Russell; Scott L Nyberg Journal: Liver Transpl Date: 2015-03-12 Impact factor: 5.799
Authors: Raymond D Hickey; Shennen A Mao; Jaime Glorioso; Faysal Elgilani; Bruce Amiot; Harvey Chen; Piero Rinaldo; Ronald Marler; Huailei Jiang; Timothy R DeGrado; Lukkana Suksanpaisan; Michael K O'Connor; Brittany L Freeman; Samar H Ibrahim; Kah Whye Peng; Cary O Harding; Chak-Sum Ho; Markus Grompe; Yasuhiro Ikeda; Joseph B Lillegard; Stephen J Russell; Scott L Nyberg Journal: Sci Transl Med Date: 2016-07-27 Impact factor: 17.956
Authors: Yue Yu; Hongling Liu; Yasuhiro Ikeda; Bruce P Amiot; Piero Rinaldo; Stephen A Duncan; Scott L Nyberg Journal: Stem Cell Res Date: 2012-06-28 Impact factor: 2.020
Authors: James E Fisher; Joseph B Lillegard; Travis J McKenzie; Brian R Rodysill; Peter J Wettstein; Scott L Nyberg Journal: Liver Transpl Date: 2013-03 Impact factor: 5.799